Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > ARCA biopharma, Inc. (ABIO)

Welcome to the board!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
~S.B.A.~ Member Profile
 
Followed By 119
Posts 4,572
Boards Moderated 0
Alias Born 01/29/12
160x600 placeholder
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 11/20/2014 4:11:27 PM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) "Edgar (US Regulatory)" - 11/12/2014 5:25:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/19/2014 5:15:27 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/19/2014 5:14:34 PM
LabCorp/ARCA biopharma GENETIC-AF Poster Presented at the 18th Annual Scientific Meeting of the Heart Failure Society of Amer... "Business Wire" - 9/16/2014 8:00:00 AM
LabCorp/ARCA biopharma GENETIC-AF Poster Selected for Presentation at the 18th Annual Scientific Meeting of the Heart Failure... "Business Wire" - 9/8/2014 8:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) "Edgar (US Regulatory)" - 8/18/2014 5:00:41 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/18/2014 4:18:06 PM
ARCA biopharma Announces Health Canada Acceptance of Genetic-AF Clinical Trial Application "Business Wire" - 8/18/2014 8:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) "Edgar (US Regulatory)" - 6/9/2014 5:01:08 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/9/2014 4:29:51 PM
Robert E. Conway Elected Chairman of ARCA biopharma Board of Directors "Business Wire" - 6/9/2014 8:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) "Edgar (US Regulatory)" - 5/14/2014 6:02:53 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/13/2014 5:29:15 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 5/7/2014 6:01:24 AM
ARCA biopharma to Present at the Growth Capital Expo 2014 "Business Wire" - 4/22/2014 9:00:00 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 4/18/2014 4:28:32 PM
ARCA biopharma Announces Screening of First Patient in Phase 2B/3 Clinical Trial Evaluating Gencaro in Atrial Fibrillation "Business Wire" - 4/17/2014 8:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 4/15/2014 5:03:51 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/15/2014 5:01:21 PM
ARCA biopharma Files Shelf Registration Statement "Business Wire" - 4/4/2014 4:05:00 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 4/4/2014 3:47:42 PM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) "Edgar (US Regulatory)" - 3/21/2014 6:12:54 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist